66 results
DEFA14A
AMTI
Applied Molecular Transport Inc.
15 Dec 23
Additional proxy soliciting materials
4:06pm
as net operating profit after tax, less changes in net working capital, plus depreciation and amortization), that Cyclo was expected to generate during
8-K
AMTI
Applied Molecular Transport Inc.
15 Dec 23
Other Events
4:05pm
(“FCF”) (defined as net operating profit after tax, less changes in net working capital, plus depreciation and amortization), that Cyclo was expected
DEFM14A
AMTI
Applied Molecular Transport Inc.
21 Nov 23
Proxy related to merger
9:16am
AND AMTI COMMON STOCK
PRINCIPAL STOCKHOLDERS OF CYCLO
PRINCIPAL STOCKHOLDERS OF AMTI
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES
UNAUDITED PRO FORMA … payment or satisfaction of all tax liabilities associated with such settlement, by AMTI.
Q:
How will the rights of AMTI stockholders change after
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
Announcements
Section 6.08
Transfer Taxes
Section 6.09
Stock Exchange Listing
Section 6.10
Delisting
Section 6.11
Tax Matters
Section 6.12
Transaction …
Section 1.01
Tax
Section 3.15(u)
Tax Return
Section 3.15(u)
Taxes
Section 3.15(u)
Trade Laws
Section 9.03
Transactions
Section 1.01
Transfer Taxes
8-K
EX-2.1
hy4k6sxsvv4l
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
8-K
EX-10.1
06r3tv
24 Jul 23
Departure of Directors or Certain Officers
4:01pm
424B5
2li2cdmg
28 Mar 22
Prospectus supplement for primary offering
9:27pm
10-K/A
f3tv79idwn
25 Mar 22
Annual report (amended)
8:20am